Delivery Order SPE2DB24D1021-SPE2DB25FFAMF
- Not listed
- The Defense Logistics Agency awarded a $1,071.66 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader contract vehicle with DLA....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) under a firm fixed-price contract. The award, valued at $1,388.16, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 12, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count) at a firm fixed price ceiling value of $3,808.80. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $2,841.20 to AmerisourceBergen Drug Corp for the supply of Junel 1.5 mg-30 mcg tablets (21-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,285.28 to AmerisourceBergen Drug Corp on August 15, 2025, for Junel FE 1mg-20 168s pharmaceutical product. This is a firm fixed price, non-competitive delivery order under a larger indefinite delivery contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,142.97 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets in quantities of 28 units. This firm fixed-price delivery order, issued on July 18, 2025, is scheduled for completion by July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against an existing contract vehicle and reflects routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,727.12 to AmerisourceBergen Drug Corp for Junel Fe 1.5 mg-30 mcg tablets (28-count packaging) on September 9, 2025, with completion expected by September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,899.04 firm fixed-price contract is for the supply of the prescription drug Junel FE 1.5 mg-30 mcg tablet, which is used for contraception. The order has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Junel Fe 1mg-20 168S pharmaceutical product. This firm fixed-price delivery order, valued at $2,534.51, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is non-competitive with no set-aside designation and is scheduled for completion by August 19, 2025, with...
- The Defense Logistics Agency awarded a $6,504.66 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562119014 JUNEL FE 1 MG-20 MCG TABLET 28S. The place of performance is Conshohocken, Pennsylvania. The order period is September 11-12, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the specified medication to support DLA's logistics operations. No major subcontractors or set-aside designations were...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAMFDelivery Order
The Defense Logistics Agency awarded a $1,678.88 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA Troop Support Medical prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic drugs, vaccines, specialty medications, and related medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. The delivery order reflects the company's established capability to fulfill federal pharmaceutical supply requirements through a flexible and extensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/9/25 |